• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy.

作者信息

Zhang Jinhui, Guan Huajie, Song Cailu, Liu Lingrui, Tang Hailin, Wang Jin

机构信息

Department of Breast Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510060, China.

出版信息

Chin Med J (Engl). 2025 Feb 5;138(3):358-360. doi: 10.1097/CM9.0000000000003397. Epub 2025 Jan 3.

DOI:10.1097/CM9.0000000000003397
PMID:39748193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11771595/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2228/11771595/9bb2db930722/cm9-138-358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2228/11771595/9bb2db930722/cm9-138-358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2228/11771595/9bb2db930722/cm9-138-358-g001.jpg

相似文献

1
Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy.新辅助化疗后转移性内乳淋巴结的局部区域治疗
Chin Med J (Engl). 2025 Feb 5;138(3):358-360. doi: 10.1097/CM9.0000000000003397. Epub 2025 Jan 3.
2
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.18F-FDG PET/CT 预测乳腺癌新辅助化疗患者局部区域淋巴结受累。
Breast Cancer Res Treat. 2012 Aug;135(1):231-40. doi: 10.1007/s10549-012-2179-1. Epub 2012 Jul 28.
3
Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis.内乳淋巴结对新辅助化疗的影像学反应与乳腺癌预后
Ann Med Surg (Lond). 2022 Nov 14;84:104900. doi: 10.1016/j.amsu.2022.104900. eCollection 2022 Dec.
4
Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.乳腺癌伴同侧内乳和腋窝淋巴结受累的局部区域管理和预后因素。
Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):552-560. doi: 10.1016/j.ijrobp.2022.02.037. Epub 2022 Mar 4.
5
Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.新辅助化疗后乳腺癌的腋窝及内乳前哨淋巴结活检
Oncotarget. 2016 Nov 8;7(45):74074-74081. doi: 10.18632/oncotarget.12615.
6
Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes.伴有内乳淋巴结局部区域复发的乳腺癌患者的总生存期
Adv Radiat Oncol. 2019 Mar 1;4(3):447-452. doi: 10.1016/j.adro.2019.02.004. eCollection 2019 Jul-Sep.
7
Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.临床淋巴结阳性乳腺癌患者腋窝淋巴结新辅助化疗疗效的薄层CT评估及病理对照
Oncol Rep. 2003 Jul-Aug;10(4):985-9.
8
Internal Mammary Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer.乳腺癌新辅助化疗后内乳前哨淋巴结活检
J Breast Cancer. 2018 Dec;21(4):442-446. doi: 10.4048/jbc.2018.21.e49. Epub 2018 Oct 29.
9
Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.影像引导下局部区域经动脉化疗在不可切除结直肠癌患者中的应用：综述
Front Oncol. 2024 Aug 23;14:1464242. doi: 10.3389/fonc.2024.1464242. eCollection 2024.
10
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.在NEOSENTITURK试验MF18 - 02/18 - 03中，接受新辅助化疗后进行前哨淋巴结活检的初始临床淋巴结阳性患者的乳腺癌复发情况。
Ann Surg Oncol. 2025 Feb;32(2):952-966. doi: 10.1245/s10434-024-16472-6. Epub 2024 Dec 2.

引用本文的文献

1
PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.PRMT1介导的PARP1甲基化通过激活三阴性乳腺癌中的P65驱动肺转移和化疗耐药性。
Research (Wash D C). 2025 Sep 8;8:0854. doi: 10.34133/research.0854. eCollection 2025.
2
CircRNAs: a novel potential strategy to treat breast cancer.环状RNA：一种治疗乳腺癌的新型潜在策略。
Front Immunol. 2025 Mar 19;16:1563655. doi: 10.3389/fimmu.2025.1563655. eCollection 2025.
3
Preoperative integrated oxidative stress score as a prognostic factor for predicting clinical outcomes in breast cancer patients received neoadjuvant chemotherapy: a real-world retrospective study.

本文引用的文献

1
Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.乳腺癌伴同侧内乳和腋窝淋巴结受累的局部区域管理和预后因素。
Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):552-560. doi: 10.1016/j.ijrobp.2022.02.037. Epub 2022 Mar 4.
2
Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.选择性内乳淋巴结照射对淋巴结阳性乳腺癌患者无病生存的影响：一项随机 3 期临床试验。
JAMA Oncol. 2022 Jan 1;8(1):96-105. doi: 10.1001/jamaoncol.2021.6036.
3
术前综合氧化应激评分作为预测接受新辅助化疗的乳腺癌患者临床结局的预后因素：一项真实世界回顾性研究
Int J Med Sci. 2025 Feb 26;22(6):1437-1449. doi: 10.7150/ijms.109915. eCollection 2025.
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
乳腺癌新辅助化疗耐药研究新进展。
Int J Mol Sci. 2021 Sep 6;22(17):9644. doi: 10.3390/ijms22179644.
4
Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021.浸润性乳腺癌诊断和治疗临床实践指南：中国乳腺外科医师协会（CSBrS）2021版实践指南
Chin Med J (Engl). 2021 Apr 28;134(9):1009-1013. doi: 10.1097/CM9.0000000000001498.
5
Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management.临床腋窝淋巴结阳性乳腺癌的内乳哨淋巴结活检：诊断及对患者管理的影响。
Ann Surg Oncol. 2020 Feb;27(2):375-383. doi: 10.1245/s10434-019-07705-0. Epub 2019 Aug 12.
6
International Variation in Criteria for Internal Mammary Chain Radiotherapy.国际内部乳状链放射治疗标准的差异。
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):453-461. doi: 10.1016/j.clon.2019.04.007. Epub 2019 May 3.
7
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.**译文**： **术后放疗对乳腺癌复发和 20 年死亡率的影响：22 项随机试验 8135 名患者个体数据的荟萃分析**
Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19.
8
Risk of ischemic heart disease in women after radiotherapy for breast cancer.乳腺癌放疗后女性患缺血性心脏病的风险。
N Engl J Med. 2013 Mar 14;368(11):987-98. doi: 10.1056/NEJMoa1209825.